References
1a
Ruault P.
Pilard JF.
Touaux B.
Texier-Boullet F.
Hamelin J.
Synlett
1994,
935
1b
Danks TN.
Tetrahedron Lett.
1999,
40:
3957
1c
Minetto G.
Raveglia LF.
Taddei M.
Org. Lett.
2004,
6:
389
1d
Bharadwaj AR.
Scheidt KA.
Org. Lett.
2004,
6:
2465
2a
Forenza S.
Minale L.
Riccio R.
J. Chem. Soc., Chem. Commun.
1971,
1129
2b
Garcia EE.
Benjamin LE.
Fryer RI.
J. Chem. Soc., Chem. Commun.
1973,
78
2c
Lindel T.
Hochgürtel M.
J. Org. Chem.
2000,
65:
2806
3a
Albizati KF.
Faulkner DJ.
J. Org. Chem.
1985,
50:
4163
3b
Xu Y.
Yakushijin K.
Horne DA.
Tetrahedron Lett.
1996,
37:
8121
4a
Cafieri F.
Fattorusso E.
Mangoni A.
Taglialatela-Scafati O.
Tetrahedron Lett.
1995,
36:
7893
4b
Marchais S.
Mourabit A.
Ahond A.
Poupat C.
Potier P.
Tetrahedron Lett.
1999,
40:
5519
5a
Palermo JA.
Brasco MFR.
Seldes AM.
Tetrahedron
1996,
52:
2727
5b
Ebel H.
Terpin A.
Steglich W.
Tetrahedron Lett.
1998,
39:
9165
6a
Bailly C.
Chaires JB.
Bioconjugate Chem.
1998,
9:
513
6b
Dyatkina NB.
Roberts CD.
Keicher JD.
Dai Y.
Nadherny JP.
Zhang W.
Schmitz U.
Kongpachith A.
Fung K.
Novikov AA.
Lou L.
Velligan M.
Khorlin AA.
Chen MS.
J. Med. Chem.
2002,
45:
805
6c
Bürli RW.
Ge Y.
White S.
Baird EE.
Touami SM.
Taylor M.
Kaizerman JA.
Moser HE.
Bioorg. Med. Chem. Lett.
2002,
12:
2591
7a
Lombardi P.
Crisanti A.
Pharmacol. Ther.
1997,
76:
125
7b
Pinna GA.
Pirisi MA.
Chelucci G.
Mussinu JM.
Murineddu G.
Loriga G.
D’Aquila PS.
Serra G.
Bioorg. Med. Chem.
2002,
10:
2485
7c
Silvestri R.
La Regina G.
De Martino G.
Artico M.
Befani O.
Palumbo M.
Agostinelli E.
Turini P.
J. Med. Chem.
2003,
46:
917
7d
Manley JM.
Kalman MJ.
Conway BG.
Ball CC.
Havens JL.
Vaidyanathan R.
J. Org. Chem.
2003,
68:
6447
8a
Bergtrom DE.
Zhang P.
Johnson WT.
Nucleosides, Nucleotides Nucleic Acids
1996,
15:
59
8b
Nairne RJD.
Pickering L.
Smith CL.
Tetrahedron Lett.
2002,
43:
2289
9a
Knorr L.
Chem. Ber.
1884,
17:
1635
9b
Paal C.
Chem. Ber.
1885,
18:
367
10a
Brummond KM.
Mitasev B.
Org. Lett.
2004,
6:
2245
10b
Brummond KM.
Curran DP.
Mitasev B.
Fischer S.
J. Org. Chem.
2005,
in press
11a
Suzuki M.
Kimura Y.
Terashima S.
Bull. Chem. Soc. Jpn.
1986,
59:
3559
11b
Stetter H.
Skobel H.
Chem. Ber.
1987,
120:
643
12 After 10-15 seconds, the desired temperature was reached and only less than 15 W were applied for the rest of the time.
Procedure for the Synthesis of Pyrroles 7.
To a solution of 20.0 mg (0.0374 mmol) 5 in EtOH (400 µL) in an Emrys Process Vial (0.5-2 mL) was added glacial acetic acid (40 µL) and 3 equiv amine 6. In the case of hydrochloride ammonium salts 1.5 equiv Et3N were added for each equivalent HCl. The microwave tube was sealed without using an inert gas atmosphere and irradiated in an Emrys Optimizer microwave at 80 °C (IR temperature detection) using an initial power of 150 W (unless otherwise mentioned). If the reaction was performed under conventional heating the same microwave tube was immersed into a preheated oil bath. In both cases the progress of the reaction was followed by TLC. Then the tube was opened and the EtOH was removed in a Radleys GreenHouse Blowdown Evaporator. The crude reaction mixture was purified by column chromatography over silica gel eluting with hexanes-EtOAc.
13a Reactions at higher temperatures: For reactions in the microwave at 130 °C and 160 °C an initial power of 250 W was necessary.
13b Reaction under diluted conditions: 20.0 mg (0.0374 mmol) 5 was dissolved in EtOH (1.2 mL) and glacial acetic acid (120 µL) and 10 equiv amine were necessary to drive the reaction to completion.
13c Aqueous acidic workup: After the reaction was complete EtOAc (10 mL) and 1 M aq HCl (10 mL) was added. The aqueous phase was extracted three times with EtOAc (10 mL), then the combined organic phases were washed with brine and dried over MgSO4. After evaporation of the solvents, the crude material was purified by column chromatography.
13d Reaction under inert gas conditions: The microwave tube was flushed with argon prior to irradiation in the microwave.
14
Physical Data for
rac
-(3b
R
,4
R
,6a
S
)-5-Benzoyl-4-(4-fluorobenzyl)-1-(2-methoxyethyl)-2-(pyrrolidine-1-carbonyl)-3b,4,5,6,6a,7-hexahydro-1
H
-1,5-diazacyclo-penta[
a
]pentalene-4-carboxylic Acid Methyl Ester (7a).
Mp 95-97 °C. IR: 2949, 2873, 1734, 1640, 1604, 1509, 1446, 1399 cm-1. 1H NMR (CDCl3): δ = 7.43-7.38 (m, 5 H), 7.31 (dd, 2 H, J = 8.4, 5.5 Hz), 7.04 (app. t, 2 H, J = 8.6 Hz), 6.22 (s, 1 H), 4.33 (ddd, 1 H, J = 13.9, 5.6, 4.2 Hz), 4.20 (d, 1 H, J = 13.8 Hz), 4.08 (ddd, 1 H, J = 14.0, 6.0, 4.4 Hz), 3.83 (d, 1 H, J = 7.4 Hz), 3.68-3.55 (m, 9 H), 3.40-3.34 (m, 2 H), 3.24-3.20 (m, 4 H), 2.60 (dd, 1 H, J = 15.3, 7.0 Hz), 2.38-2.29 (m, 1 H), 2.27 (d, 1 H, J = 15.9 Hz), 1.98-1.89 (m, 4 H). 13C (CDCl3): δ = 172.0, 169.8, 161.8, 161.8 (d, J
CF = 243.9 Hz), 141.6, 137.3, 132.6 (d, J
CF = 3.1 Hz), 132.2 (d, J
CF = 7.7 Hz), 129.5, 129.1, 128.3, 126.0, 121.8, 114.9 (d, J
CF = 20.9 Hz), 108.8, 72.9, 72.8, 58.6, 56.2, 52.1, 51.9, 49 (br), 46.9, 46 (br), 45.2, 38.4, 28.6, 27 (br), 24 (br). 19F NMR (CDCl3): δ = -116.5 (tt, 1 F, J = 8.5, 5.6 Hz). MS (ESI): m/z (rel. intensity) = 596 (100) [M+ + Na], 574 (72) [M+ + H], 514 (30). HRMS (ESI): m/z calcd for C33H36N3O5FNa: 595.2537; found: 596.2544.